Pro-Hamas Activists Tried Harassing a GOP Congresswoman. It Didn't Go Well.
Let Them Destroy Each Other
Biden’s a Boon for America’s Foes
Seems Odd That Democrats Still Don’t Get This About Trump
Unveiling the Myth: Democrats, PRRI, and the Christian Nationalist Specter
Bibi Ignores Biden
This Has Never Been About Justice
MSNBC Host: Donald Trump, Like Richard Nixon, Is Racist
If You Can't Tell the Bad Guy in Israel Versus Hamas, You're the...
Why Communism and Socialism Fail
Defying Odds, Biden Figures Out a Way to Make Federal Permitting Law Even...
The 'Death to America' Crowd
A Message to VP Kamala Harris- Respect the Other Side of Choice
The 'Death to America' Crowd
The Most Dangerous People in America: College Professors
Tipsheet

Rep. Maloney: Republicans Would Reject Cancer Cure

On top of being terrorists and hostage takers, Democrat Rep. Carolyn Maloney apparently thinks Republicans hate cancer patients  because they wouldn't budge on tax hikes during the debt debate.

Advertisement

"If President Obama came in with a cure for cancer they would have turned that down, too," she said.

FLASHBACK: Rationing for cancer patients begins through ObamaCare.

A decision to rescind endorsement of the drug would reignite the highly charged debate over US health care reform and how much the state should spend on new and expensive treatments.

Avastin, the world’s best selling cancer drug, is primarily used to treat colon cancer and was approved by the US Food and Drug Administration in 2008 for use on women with breast cancer that has spread.

It costs $8,000 (£5,000) a month and is given to about 17,500 women in the US a year. The drug was initially approved after a study found that, by preventing blood flow to tumours, it extended the amount of time until the disease worsened by more than five months. However, two new studies have shown that the drug may not even extend life by an extra month.

The FDA advisory panel has now voted 12-1 to drop the endorsement for breast cancer treatment. The panel unusually cited "effectiveness" grounds for the decision. But it has been claimed that "cost effectiveness" was the real reason ahead of reforms in which the government will extend health insurance to the poorest.

 

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement